Jaya Thangaraj

Title(s)	Postdoctoral Scholar, Medicine
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells. Cell Stem Cell. 2024 Sep 05; 31(9):1327-1343.e5. Thangaraj JL, Coffey M, Lopez E, Kaufman DS. PMID: 38986609; PMCID: PMC11380586.

View in: PubMed Mentions: 4 Fields:
Cel Cell Biology
Translation:Humans Animals Cells
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model. J Immunother Cancer. 2024 May 03; 12(5). Yun J, Saddawi-Konefka R, Goldenson B, Al-Msari R, Bernareggi D, Thangaraj JL, Tang S, Patel SH, Luna SM, Gutkind JS, Kaufman D. PMID: 38702144; PMCID: PMC11086353.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms The Therapeutics
Translation:Humans Animals Cells
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model. Front Immunol. 2022; 13:1009484. Tran TA, Kim YH, Duong TH, Thangaraj J, Chu TH, Jung S, Kim IY, Moon KS, Kim YJ, Lee TK, Lee CW, Yun H, Lee JJ, Lee HJ, Lee KH, Jung TY. PMID: 36703992; PMCID: PMC9871756.

View in: PubMed Mentions: 4 Fields:
All Allergy and Immunology
Translation:Humans Animals Cells
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model. Cancer Immunol Immunother. 2023 May; 72(5):1233-1246. Thangaraj JL, Jung SH, Vo MC, Chu TH, Phan MT, Lee KH, Ahn SY, Kim M, Song GY, Ahn JS, Yang DH, Kim HJ, Cho D, Lee JJ. PMID: 36385211; PMCID: PMC10110729.

View in: PubMed Mentions: 5 Fields:
All Allergy and Immunology Neo Neoplasms The Therapeutics
Translation:Humans Animals Cells
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21. Cancer Immunol Immunother. 2022 Mar; 71(3):613-625. Thangaraj JL, Phan MT, Kweon S, Kim J, Lee JM, Hwang I, Park J, Doh J, Lee SH, Vo MC, Chu TH, Song GY, Ahn SY, Jung SH, Kim HJ, Cho D, Lee JJ. PMID: 34282497; PMCID: PMC10991462.

View in: PubMed Mentions: 12 Fields:
All Allergy and Immunology Neo Neoplasms The Therapeutics
Translation:Humans Cells
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cell Mol Immunol. 2021 07; 18(7):1652-1661. Thangaraj JL, Ahn SY, Jung SH, Vo MC, Chu TH, Thi Phan MT, Kwon M, Lee KH, Kim M, Song GY, Yang DH, Ahn JS, Kim HJ, Cho D, Lee JJ. PMID: 33980993; PMCID: PMC8245645.

View in: PubMed Mentions: 16 Fields:
All Allergy and Immunology
Translation:Humans Animals Cells